| Stage | APO | % of rev | BX | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $11.2B | 100.00% | $5.0B | 100.00% | APO ×2.21 |
| Gross profit | $10.2B | 91.69% | $5.0B | 100.00% | BX +8.3pp |
| Operating income | $2.4B | 21.63% | $2.7B | 52.90% | BX +31.3pp |
| Pre-tax income | $2.5B | 22.28% | $2.8B | 55.68% | BX +33.4pp |
| Net income | $2.1B | 18.73% | $2.4B | 46.71% | BX +28.0pp |
| Stage | APO | BX | Gap · A − B |
|---|---|---|---|
| Revenue | $11.2B100.00% | $5.0B100.00% | APO ×2.21 |
| Gross profit | 91.69%$10.2B | 100.00%$5.0B | BX +8.3pp |
| Operating income | 21.63%$2.4B | 52.90%$2.7B | BX +31.3pp |
| Pre-tax income | 22.28%$2.5B | 55.68%$2.8B | BX +33.4pp |
| Net income |
| 18.73%$2.1B |
| 46.71%$2.4B |
| BX +28.0pp |
No shared counterparties.